Comments on National Health Commission guidelines for diagnosis and treatment of colorectal cancer 2023 in China (English version)

Yong Yang, Zhaoya Gao, Jin Gu

2023, 35(5): 431-432. doi: 10.21147/j.issn.1000-9604.2023.05.01

Advances, breakthroughs, and challenges in gastric cancer surgery

Hayun Kim, Sungsoo Park

2023, 35(5): 433-437. doi: 10.21147/j.issn.1000-9604.2023.05.02

Epidemiology of pancreatic cancer: New version, new vision

Wenhao Luo, Jun Wang, Hao Chen, Liyuan Ye, Jiangdong Qiu, Yueze Liu, Ruobing Wang, Guihu Weng, Tao Liu, Dan Su, Jinxin Tao, Chen Ding, Lei You, Taiping Zhang

2023, 35(5): 438-450. doi: 10.21147/j.issn.1000-9604.2023.05.03

MRD-directed and risk-adapted individualized stratified treatment of AML

Yijing Zhao, Hanfei Guo, Yingjun Chang

2023, 35(5): 451-469. doi: 10.21147/j.issn.1000-9604.2023.05.04

Inspired by novel radiopharmaceuticals: Rush hour of nuclear medicine

Yang Liu, Ya-nan Ren, Yan Cui, Song Liu, Zhi Yang, Hua Zhu, Nan Li

2023, 35(5): 470-482. doi: 10.21147/j.issn.1000-9604.2023.05.05

Update of latest data for combined therapy for esophageal cancer using radiotherapy and immunotherapy: A focus on efficacy, safety, and biomarkers

Shuping Cheng, Butuo Li, Jinming Yu, Linlin Wang

2023, 35(5): 483-500. doi: 10.21147/j.issn.1000-9604.2023.05.06

Genetic susceptibility loci of lung cancer are associated with malignant risk of pulmonary nodules and improve malignancy diagnosis based on CEA levels

Zhi Li, Liming Lu, Yibin Deng, Amei Zhuo, Fengling Hu, Wanwen Sun, Guitian Huang, Linyuan Liu, Boqi Rao, Jiachun Lu, Lei Yang

2023, 35(5): 501-510. doi: 10.21147/j.issn.1000-9604.2023.05.07

A novel multimodal prediction model based on DNA methylation biomarkers and low-dose computed tomography images for identifying early-stage lung cancer

Jing Zhang, Haohua Yao, Chunliu Lai, Xue Sun, Xiujuan Yang, Shurong Li, Yubiao Guo, Junhang Luo, Zhihua Wen, Kejing Tang

2023, 35(5): 511-525. doi: 10.21147/j.issn.1000-9604.2023.05.08

Baseline radiologic features as predictors of efficacy in patients with pancreatic neuroendocrine tumors with liver metastases receiving surufatinib

Jianwei Zhang, Haibin Zhu, Lin Shen, Jie Li, Xiaoyan Zhang, Chunmei Bai, Zhiwei Zhou, Xianrui Yu, Zhiping Li, Enxiao Li, Xianglin Yuan, Wenhui Lou, Yihebali Chi, Nong Xu, Yongmei Yin, Yuxian Bai, Tao Zhang, Dianrong Xiu, Jia Chen, Shukui Qin, Xiuwen Wang, Yujie Yang, Haoyun Shi, Xian Luo, Songhua Fan, Weiguo Su, Ming Lu, Jianming Xu

2023, 35(5): 526-535. doi: 10.21147/j.issn.1000-9604.2023.05.09

Genetic abnormalities assist in pathological diagnosis and EBV-positive cell density impact survival in Chinese angioimmunoblastic T-cell lymphoma patients

Yunfei Shi, Haojie Wang, Yanfei Liu, Mengping Long, Ning Ding, Lan Mi, Yumei Lai, Lixin Zhou, Xinting Diao, Xianghong Li, Weiping Liu, Jun Zhu

2023, 35(5): 536-549. doi: 10.21147/j.issn.1000-9604.2023.05.10

OpenNAU: An open-source platform for normalizing, analyzing, and visualizing cancer untargeted metabolomics data

Qingrong Sun, Qingqing Xu, Majie Wang, Yongcheng Wang, Dandan Zhang, Maode Lai

2023, 35(5): 550-562. doi: 10.21147/j.issn.1000-9604.2023.05.11